Daniel M Hartung
Affiliation: Oregon Health and Science University
- Effects of a prior-authorization policy for celecoxib on medical service and prescription drug use in a managed care Medicaid populationDaniel M Hartung
Oregon State University College of Pharmacy, Portland, USA
Clin Ther 26:1518-32. 2004..No important changes in use of other drug classes were detected. The overall increase in emergency-department visits--although not observed among previous NSAID users--should be explored on the individual level...
- A pilot study evaluating alternative approaches of academic detailing in rural family practice clinicsDaniel M Hartung
Oregon State University College of Pharmacy, Oregon Health and Science University, Portland, OR, 97239, USA
BMC Fam Pract 13:129. 2012..Our study evaluates different models of delivering academic detailing in a rural family medicine setting...
- Generic substitution of lamotrigine among medicaid patients with diverse indications: a cohort-crossover studyDaniel M Hartung
Oregon State University College of Pharmacy, Oregon Health and Science University, Portland, OR 97239, USA
CNS Drugs 26:707-16. 2012..Lamotrigine, the prototypical newer AED, is often used for psychiatric and neurological conditions other than epilepsy. The safety of generic substitution of lamotrigine in diverse populations of AED users is unclear...
- Effect of drug sample removal on prescribing in a family practice clinicDaniel M Hartung
Department of Pharmacy Practice, Oregon State University College of Pharmacy, Portland, Oregon, USA
Ann Fam Med 8:402-9. 2010..The objective of this study was to evaluate the effect of a policy prohibiting prescription drug samples and pharmaceutical industry interaction on prescribing patterns in a rural family practice clinic in central Oregon...
- Overview of clinical research designDaniel M Hartung
College of Pharmacy, Oregon State University, Portland, OR 97239, USA
Am J Health Syst Pharm 66:398-408. 2009..Basic concepts and terminology of clinical research design are presented for new clinical investigators...
- Impact of a Medicaid copayment policy on prescription drug and health services utilization in a fee-for-service Medicaid populationDaniel M Hartung
Department of Pharmacy Practice, Oregon State University College of Pharmacy, Portland, Oregon 97239 4501, USA
Med Care 46:565-72. 2008..Research exploring the effects of copays on pharmacy and health care utilization in Medicaid patients is limited, especially among patients with chronic disease...
- Rates of adverse events of long-acting opioids in a state Medicaid programDaniel M Hartung
College of Pharmacy, Oregon State University, Oregon Health and Science University Campus, Portland, OR 97239, USA
Ann Pharmacother 41:921-8. 2007..Despite widespread use and emerging safety concerns, data on the comparative safety and effectiveness of long-acting opioid (LAO) analgesics are weak...
- Initial results of the use of prescription order change forms to achieve dose form optimization (consolidation and tablet splitting) of SSRI antidepressants in a state Medicaid programAnn M Hamer
Drug Use Research and Mangement Program, Oregon State University College of Pharmacy, Portland, OR 97201 4952, USA
J Manag Care Pharm 12:449-56. 2006..Dose form optimization can reduce the direct cost of therapy by up to 50% while continuing the same daily dose of the same drug molecule...
- Patterns of atypical antipsychotic subtherapeutic dosing among Oregon Medicaid patientsDaniel M Hartung
Oregon State University, Portland, USA
J Clin Psychiatry 69:1540-7. 2008....
- Risk of hospitalization for heart failure associated with thiazolidinedione therapy: a medicaid claims-based case-control studyDaniel M Hartung
College of Pharmacy, Oregon State University, Portland, Oregon, USA
Pharmacotherapy 25:1329-36. 2005..When thiazolidinediones are prescribed, careful consideration should be given to patients with known heart failure. In addition, all patients should be educated regarding heart failure and monitored for signs and symptoms...
- An evaluation of Oregon's evidence-based Practitioner-Managed Prescription Drug PlanDaniel M Hartung
Drug Use Research and Management Program, College of Pharmacy, Oregon State University, Portland, USA
Health Aff (Millwood) 25:1423-32. 2006..1 percent and 17.7 percent after implementation of the DAW and soft PA policies, respectively. Data from nonenforced PMPDP classes showed no change; this suggests the need for effective methods to encourage PMPDP compliance...
- Clinical implications of an accurate problem list on heart failure treatmentDaniel M Hartung
Oregon State University College of Pharmacy, Portland, OR, USA
J Gen Intern Med 20:143-7. 2005..CONCLUSION: Accurate documentation of heart failure on the problem list of patients with known systolic dysfunction is associated with a significant increase in the likelihood of being prescribed medications with known clinical benefit...
- Breaking Up is Hard to Do: Lessons Learned from a Pharma-Free Practice TransformationDavid Evans
The Department of Family Medicine, University of Washington School of Medicine, Seattle the Department of Pharmacy Practice, Oregon State University College of Pharmacy, Portland and the Department of Family Practice, Oregon Health and Science University School of Medicine, Oregon Rural Practice Based Research Network, Portland
J Am Board Fam Med 26:332-8. 2013..Little guidance for practicing physicians exists about transforming practices to become pharma-free. Consideration must be given to the impact on practice culture, staff views, and patient needs...
- Risk factors associated with linezolid-nonsusceptible enterococcal infectionsJessina C McGregor
College of Pharmacy, Oregon State University Oregon Health and Science University, Portland, OR 97239, USA
Am J Infect Control 40:886-7. 2012..Previous hospitalization, admission to a medical service, comorbidity, and linezolid and sulfonamide therapy were identified as risk factors...